Myovant Sciences Ltd. Proceeds from Common Stock Issued
Myovant Sciences Ltd. reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-05-11
- Myovant Sciences Ltd. proceeds from issuance of common stock for the quarter ending 2018-03-31 was $0.00.
- Myovant Sciences Ltd. proceeds from issuance of common stock for the quarter ending 2017-03-31 was $0.00.
- Myovant Sciences Ltd. proceeds from issuance of common stock for fiscal 2022 was $0.00.
- Myovant Sciences Ltd. proceeds from issuance of common stock for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Myovant Sciences Ltd. proceeds from issuance of common stock for fiscal 2020 was $137.00M, a 37.42% decline from fiscal 2019.
- Myovant Sciences Ltd. proceeds from issuance of common stock for fiscal 2019 was $218.93M, a 11689.18% increase from fiscal 2018.
| Period end | Proceeds from Issuance of Common Stock 2 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|
| 2022-03-31 | $0.00 10-K · filed 2022-05-11 | ||||
| 2021-03-31 | $0.00 10-K · filed 2022-05-11 | ||||
| 2020-03-31 | $137.00M 10-K · filed 2022-05-11 | ||||
| 2019-03-31 | $218.93M 10-K · filed 2021-05-11 | $37.98M 10-K · filed 2019-05-24 | |||
| 2018-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-24 | $1.86M 10-K · filed 2019-05-24 | |||
| 2017-12-31 | $1.86M 10-Q · filed 2018-02-13 | ||||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-24 | $0.00 10-K · filed 2019-05-24 | |||
| 2016-12-31 | $0.00 10-Q · filed 2018-02-13 | ||||
| 2016-03-31 | $0.00 10-K · filed 2018-06-07 |